UNSPSC 51383001: Fenflumizol or fenflumizole

This classification denotes a cyclooxygenase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PD0931191Q. European Medicines Agency schedules Fenflumizole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13827MIG. Fenflumizol generally arises in the molecular formula C23H18F2N2O2. The term FENFLUMIZOL is an International Non-Proprietary Name or INN. FENFLUMIZOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Fenflumizol or fenflumizole bears US NLM identifiers UMLS ID C0060168 and NCI Concept Code C65648. SMILES: FC1C(C2[NH]C(C(N2)C2CCC(OC)CC2)C2CCC(OC)CC2)CCC(F)C1.

UNSPSC 51383001 Fenflumizol or fenflumizole, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities in the dataset — Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's request for information on direct-to-manufacturer prescription programs, and MMCAP's multi-state RFP for generic pharmaceuticals and OTC products — involve naloxone, prescription fulfillment infrastructure, and broad-spectrum generic medication sourcing, none of which fall within the scope of fenflumizol or fenflumizole compounds. The code shows little relevant recent activity at the state and local level, and the opportunities present in the dataset appear to reflect tagging misalignment rather than genuine procurement demand under this commodity classification.

Without recent opportunities that authentically fall within the fenflumizol or fenflumizole scope, geographic concentration, issuing-body patterns, and representative solicitation detail cannot be reliably characterized from the available source material. Firms evaluating this code should treat current activity as negligible and monitor for future opportunities that accurately reflect the commodity's intended scope rather than rely on the present dataset for market signals or procurement patterns.